We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 859 results
  1. Diverse activity of miR-150 in Tumor development: shedding light on the potential mechanisms

    There is a growing interest to understand the role and mechanism of action of microRNAs (miRNAs) in cancer. The miRNAs are defined as short...

    Ali Ameri, Hani Moslem Ahmed, ... Omid Yazdani in Cancer Cell International
    Article Open access 03 November 2023
  2. Integrating network pharmacology and experimental validation to decipher the mechanism of action of **gfang Granule in the treatment of viral myocarditis

    This study investigated the mechanisms of **gfang Granule (JFG) in viral myocarditis (VMC) treatment via network pharmacology-based approach...

    Tian Yao, Bowen Sun, ... Chao Li in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 24 March 2023
  3. Neuroinflammation regulates the balance between hippocampal neuron death and neurogenesis in an ex vivo model of thiamine deficiency

    Background

    Thiamine (vitamin B1) is a cofactor for enzymes of central energy metabolism and its deficiency (TD) impairs oxidative phosphorylation,...

    Larissa M. G. Cassiano, Marina S. Oliveira, ... Roney S. Coimbra in Journal of Neuroinflammation
    Article Open access 14 November 2022
  4. DeepSTARR predicts enhancer activity from DNA sequence and enables the de novo design of synthetic enhancers

    Enhancer sequences control gene expression and comprise binding sites (motifs) for different transcription factors (TFs). Despite extensive genetic...

    Bernardo P. de Almeida, Franziska Reiter, ... Alexander Stark in Nature Genetics
    Article 12 May 2022
  5. Histone deacetylase 3 (HDAC3) as an important epigenetic regulator of kidney diseases

    Development and progression of many kidney diseases are substantially influenced by aberrant protein acetylation modifications of gene expression...

    Lijun Zhang, Wangsen Cao in Journal of Molecular Medicine
    Article 26 October 2021
  6. Combining network pharmacology and experimental verification to reveal the mechanism of Chaigui granules in the treatment of depression through PI3K/Akt/mTOR signaling pathways

    Introduction

    Chaigui granules are a novel manufactured traditional Chinese antidepressant medicine, which is originated from the ancient classical...

    Jun-sheng Tian, Zhen-ning Wu, ... Xue-mei Qin in Metabolic Brain Disease
    Article 31 October 2023
  7. Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential

    HOXA9 functioning as a transcription factor is one of the members of HOX gene family, which governs multiple cellular activities by facilitating...

    Ling Tang, Lin Peng, ... Hui Wang in Cancer Cell International
    Article Open access 14 November 2022
  8. Molecular evolutionary process of advanced gastric cancer during sequential chemotherapy detected by circulating tumor DNA

    Background

    Efficacy of conventional sequential chemotherapy paradigm for advanced gastric cancer (AGC) patients has largely plateaued. Dynamic...

    Wenqi **, Chenfei Zhou, ... Jun Zhang in Journal of Translational Medicine
    Article Open access 12 August 2022
  9. Identification of Potential Biomarkers for Patients with DWI-Negative Ischemic Stroke

    Ischemic stroke is the leading cause of long-term disability in adults, accounting for 80% of stroke cases. Diffusion weighted imaging (DWI)...

    Lei Li, Ying Wang in Journal of Molecular Neuroscience
    Article Open access 12 July 2024
  10. Genes in Axonal Regeneration

    This review explores the molecular and genetic underpinnings of axonal regeneration and functional recovery post-nerve injury, emphasizing its...

    Wenshuang Wu, **g Zhang, ... **nghui Wang in Molecular Neurobiology
    Article 22 February 2024
  11. Verapamil attenuates scopolamine induced cognitive deficits by averting oxidative stress and mitochondrial injury – A potential therapeutic agent for Alzheimer’s Disease

    Alzheimer’s disease (AD) is a multifactorial disorder where amyloid beta (Aβ) plaques, Ca 2+ dysregulation, excessive oxidative stress, mitochondrial...

    Saravanaraman Ponne, Chinnadurai Raj Kumar, Rathanam Boopathy in Metabolic Brain Disease
    Article 05 November 2019
  12. A multi-omics approach to elucidate okadaic acid-induced changes in human HepaRG hepatocarcinoma cells

    Okadaic acid (OA), a prevalent marine biotoxin found in shellfish, is known for causing acute gastrointestinal symptoms. Despite its potential to...

    Leonie T. D. Wuerger, Heike Sprenger, ... Albert Braeuning in Archives of Toxicology
    Article Open access 04 June 2024
  13. Identification of Systems Level Molecular Signatures from Glioblastoma Multiforme Derived Extracellular Vesicles

    Glioblastoma multiforme (GBM) is one of the most lethal malignancies of the central nervous system characterized by high mortality rate. The...

    Nabanita Roy, Mithil Gaikwad, ... Pankaj Barah in Journal of Molecular Neuroscience
    Article 24 November 2020
  14. Tet3 Deletion in Adult Brain Neurons of Female Mice Results in Anxiety-like Behavior and Cognitive Impairments

    TET enzymes (TET1-3) are dioxygenases that oxidize 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) and are involved in the DNA...

    Cláudia Antunes, Jorge D. Da Silva, ... C. Joana Marques in Molecular Neurobiology
    Article 03 June 2022
  15. Protein regulator of cytokinesis 1: a potential oncogenic driver

    Protein regulator of cytokinesis 1 (PRC1) is involved in cytokinesis. Growing evidence suggests the association of PRC1 with multiple cancers. Here,...

    Si**g Li, Omar Motiño, ... Guido Kroemer in Molecular Cancer
    Article Open access 10 August 2023
  16. Off the Clock: the Non-canonical Roles of Cyclin-Dependent Kinases in Neural and Glioma Stem Cell Self-Renewal

    Glioma stem cells (GSCs) are thought to drive growth and therapy resistance in glioblastoma (GBM) by “hijacking” at least a subset of signaling...

    Ling-Kai Shih, Subhas Mukherjee, Daniel J. Brat in Molecular Neurobiology
    Article 31 August 2022
  17. Huntington’s Disease and Neurodegeneration

    Huntington’s disease (HD) is an autosomal dominant disorder caused by a CAG repeat expansion within the coding region of the Huntingtin (HTT) gene....
    Annika Heinz, Deepti Kailash Nabariya, Sybille Krauß in Handbook of Neurotoxicity
    Reference work entry 2022
  18. Stressor control and regional inflammatory responses in the brain: regulation by the basolateral amygdala

    Increasing evidence has connected the development of certain neuropsychiatric disorders, as well as neurodegenerative diseases, to stress-induced...

    Austin M. Adkins, Emily M. Colby, ... Larry D. Sanford in Journal of Neuroinflammation
    Article Open access 27 May 2023
  19. Exploring the active components and potential mechanisms of Alpiniae oxyphyllae Fructus in treating diabetes mellitus with depression by UPLC-Q-Exactive Orbitrap/MS, network pharmacology and molecular docking

    The growing incidence of diabetes mellitus (DM) and depression is a global public health issue. Alpiniae oxyphyllae Fructus (AOF) is a kind of...

    Yue Qi, Qilun Zhou, ... **aofeng Zhang in Metabolic Brain Disease
    Article 02 July 2024
  20. DNA methylation and type 2 diabetes: a systematic review

    Objective

    DNA methylation influences gene expression and function in the pathophysiology of type 2 diabetes mellitus (T2DM). Map** of...

    Nikhil Nadiger, Jyothisha Kana Veed, ... Arpita Mukhopadhyay in Clinical Epigenetics
    Article Open access 16 May 2024
Did you find what you were looking for? Share feedback.